BeginNGS Archives | Page 3 of 4

Media Coverage
September 23, 2022

Building a Pipeline of Therapies to Treat Rare Mineralization Disorders

Global Genes Podcast

GLOBAL GENES PODCAST: Global Genes spoke to spoke to Axel Bolte, co-founder and CEO of Inozyme, about ENPP1 deficiency, its lead experimental therapy to treat the condition, and its work with Rady Children’s Institute for Genomic Medicine to improve the diagnosis of newborns.

Media Coverage
August 25, 2022

BeginNGS Program Seeks to Improve Pediatric Rare Disease Dx, Treatment via Rapid NGS, Data Curation

GenomeWeb

GENOMEWEB: In a paper published this week in the American Journal of Human Genetics, collaborators led by the Rady Children's Institute for Genomic Medicine (RCIGM) formally spelled out plans to improve detection and treatment of rare hereditary pediatric diseases through rapid whole-genome sequencing (rWGS).

Press Releases
August 24, 2022

Novel Newborn Screening System Uses Rapid Whole Genome Sequencing and Acute Management Guidance to Screen and Diagnosis Genetic Diseases

Study demonstrates feasibility of NBS-rWGS prototype to rapidly screen for several hundred genetic diseases with effective interventions

Media Coverage
August 22, 2022

From Guthrie to Genomes: The Continued Evolution of Newborn Screening

CDC Genomics & Precision Health Blog

The CDC Genomics & Precision Health blog reviews the state of newborn screening today, including the BeginNGS program.

Media Coverage
August 10, 2022

Advancing Newborn Screening For Rare Genetic Diseases

EP Magazine

EP Magazine: Researchers, industry, and patient advocacy groups are driving efforts to facilitate early diagnosis and improve babies' long-term outlook. Commentary by Catherine Nester, BSN, Inozyme's VP of Physician and Patient Strategies.

Press Releases
July 26, 2022

Study Supports Potential of Genome-to-Treatment (GTRx™) to Guide Physicians in the Management of 500 Treatable Genetic Diseases

Media Coverage
July 25, 2022

The earlier the better: New consortium leverages infant screening to accelerate treatment

PharmaVoice

PHARMAVOICE: Newborn screening is gaining prominence across the biopharma and healthcare industries amid efforts to detect and treat disease as early as possible.

Media Coverage
June 16, 2022

Rady Children’s Institute for Genomic Medicine Partners With Inozyme Pharma on NGS Newborn Screening

GenomeWeb

Media Coverage
June 15, 2022

Rady Children’s Institute launches newborn genetic disease screening

LabPulse.com

Media Coverage
June 15, 2022

New Rady program will screen infants for genetic threats

San Diego Union-Tribune

SD UNION-TRIBUNE: A new initiative from the Rady Children’s Institute for Genomic Medicine hopes to screen newborns for nearly 400 genetic conditions.

News Center Archives

About us

Tag: BeginNGS

Building a Pipeline of Therapies to Treat Rare Mineralization Disorders

BeginNGS Program Seeks to Improve Pediatric Rare Disease Dx, Treatment via Rapid NGS, Data Curation

Novel Newborn Screening System Uses Rapid Whole Genome Sequencing and Acute Management Guidance to Screen and Diagnosis Genetic Diseases

From Guthrie to Genomes: The Continued Evolution of Newborn Screening

Advancing Newborn Screening For Rare Genetic Diseases

Study Supports Potential of Genome-to-Treatment (GTRx™) to Guide Physicians in the Management of 500 Treatable Genetic Diseases

The earlier the better: New consortium leverages infant screening to accelerate treatment

Rady Children’s Institute for Genomic Medicine Partners With Inozyme Pharma on NGS Newborn Screening

Rady Children’s Institute launches newborn genetic disease screening

New Rady program will screen infants for genetic threats

Partner With Us

Order a Test

About Us

STAY UP TO DATE

Follow Us

Contact Us About BeginNGS